Back |
home / stock / nlnk / nlnk message board
Subject | By | Source | When |
---|---|---|---|
Bounce coming it look like | T695 | investorshub | 04/06/2018 5:22:10 PM |
Right behind you | Picks77 | investorshub | 04/06/2018 3:39:55 PM |
panic selling off the incyte merck results., im buying | gregque | investorshub | 04/06/2018 1:26:17 PM |
http://www.barchart.com/detailedquote/stocks/$NLNK | mick | investorshub | 02/28/2018 5:57:27 PM |
Im loading up at these levels | Picks77 | investorshub | 02/10/2018 10:53:38 AM |
http://www.barchart.com/opinions/stocks/$NLNK | mick | investorshub | 01/24/2018 1:21:40 AM |
Newlink Genetics Cor ($NLNK) | mick | investorshub | 01/24/2018 1:21:33 AM |
Kelly does your DD still stand on its | Builder | investorshub | 12/26/2017 8:54:44 PM |
http://www.barchart.com/opinions/stocks/$NLNK | mick | investorshub | 12/01/2017 11:22:39 AM |
https://www.stockscores.com/charts/charts/?ticker=$NLNK | mick | investorshub | 10/08/2017 6:10:52 PM |
You're right, I have done very well in | War Shark | investorshub | 10/02/2017 11:59:28 AM |
Sweet, I think azn is a great company | KelliBlue | investorshub | 10/01/2017 11:57:28 PM |
News, Short Squeeze, Breakout and More Instantly...
Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock PR Newswire NEW ORLEANS ...
AUSTIN, Texas, March 30, 2020 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, has announced the appointment of Joseph S. McCracken, DVM, MS to the company's Board of Directors, effective March 23...
- Combined company, Lumos Pharma, Inc., to trade on Nasdaq under the stock symbol “LUMO” - Phase 2b trial expected to be initiated mid-2020 evaluating oral therapeutic candidate LUM-201 (ibutamoren) in Pediatric Growth Hormone Deficiency (PGHD) - Projected combined cash ...